Medical devices company Biotrin is to create 40 new jobs in Dublin. .
The high-end jobs are part of a new Research and Development (R&D) project in Dublin, which is being backed by the IDA.
The jobs will be in research and development, manufacturing and marketing.
The new project will involve the development of automated molecular diagnostics platform technology and will be based on a new form of technology called loop-mediated isothermal amplification (Lamp).
Biotrin is owned by Italian company, Diasorin.
The project will establish the Dublin site as Diasorin's corporate headquarters for molecular diagnostics research and development, bringing the total number of workers there to 100.
Minister for Enterprise Batt O’Keffe welcomed the announcement, saying the investment demonstrates Ireland's attractiveness for leading-edge medical device investments.
"The development of new diagnostic technologies is the type of high-end activity the Government is eager to support as part of our efforts to build the 'smart' economy and innovation island."
He said that Ireland has a strong cluster of firms in the life science sector with eight of the top 10 pharmaceutical and 15 of the top 20 medical devices companies based here. "The 40 new jobs will add to our reputation as a global leader for life science firms,' said Mr O'Keeffe.
Dr Carlo Rosa, chief executive of Diasorin, the company which owns Biotrin, said that the decision to locate the operation in Ireland was based on its strong reputation as an R&D location and on the success of Biotrin’s existing operation here.
